Synthesis and evaluation of new potential HIV-1 non-nucleoside reverse transcriptase inhibitors. New analogues of MKC-442 containing Michael acceptors in the C-6 position

Organic and Biomolecular Chemistry

Volumn 1, Issue 20, 2003, Pages 3541-3545

  Petersen, Lene ^a   Jessen, Carsten H ^a   Pedersen, Erik B ^a   Nielsen, Claus ^b  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDES; DERIVATIVES; ENZYMES; KETONES; SYNTHESIS (CHEMICAL);

MICHAEL ACCEPTORS;

AROMATIC COMPOUNDS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; STAPHYLOCOCCUS PHAGE 3A;

EID: 0142227211     PISSN: 14770520     EISSN: None     Source Type: Journal    
DOI: 10.1039/b307800k     Document Type: Article

References (30)

1. (a) H. Tanaka, H. Takashima, M. Ubasawa, K. Sekiya, N. Inouye, M. Baba, S. Shigeta, R. T. Walker, E. De Clercq and T. Miyasaka, J. Med. Chem., 1995, 38, 2860-2865
2. (b) M. Baba, S. Shigeta, S. Yuasa, H. Takashima, K. Sekiya, M. Ubasawa, H. Tanaka, T. Miyasaka, R. T. Walker and E. De Clercq, Antimicrob. Agents Chemother., 1994, 38, 688-692
3. (c) S. Yuasa, Y. Sadakata, H. Takashima, K. Sekiya, N. Inouye, M. Ubasawa and M. Baba, Mol. Pharmacol., 1993, 44, 895-900.
4. For recent reviews on NNRTI's see: (a) R. W. Buckheit, Expert Opin. Invest Drugs., 2001, 10, 1423-1442; (b) M. Hogberg and I. Morrison, Expert. Opin. Ther. Pat., 2000, 10, 1189-1199; (c) O. S. Pedersen and E. B. Pedersen, Antiviral Chem. Chemother., 1999, 10, 285-314.
5. For recent reviews on NNRTI's see: (a) R. W. Buckheit, Expert Opin. Invest Drugs., 2001, 10, 1423-1442; (b) M. Hogberg and I. Morrison, Expert. Opin. Ther. Pat., 2000, 10, 1189-1199; (c) O. S. Pedersen and E. B. Pedersen, Antiviral Chem. Chemother., 1999, 10, 285-314.
6. For recent reviews on NNRTI's see: (a) R. W. Buckheit, Expert Opin. Invest Drugs., 2001, 10, 1423-1442; (b) M. Hogberg and I. Morrison, Expert. Opin. Ther. Pat., 2000, 10, 1189-1199; (c) O. S. Pedersen and E. B. Pedersen, Antiviral Chem. Chemother., 1999, 10, 285-314.
7. G. M. Szcech, P. Furman, G. R. Painter, D. W. Barry, K. Borroto-Esoda, T. B. Grizzle, M. R. Blum, J-P. Sommadossi, R. Endoh, T. Niwa, M. Yamamoto and C. Moxham, Antimicrob. Agents Chemother., 2000, 44, 123-130.
8. rd quarter 2002 NDA submission for Coviracil® (emtricitabine) and discontinues development of Coactinon® (emivirine), Durham, NC, USA, January 17, 2002. http://www.tripharm.com.
9. A. L. Hopkins, J. Ren, R. M. Esnouf, B. E. Willcox, E. Y. Jones, C. Ross, T. Miyasaka, R. T. Walker, H. Tanaka, D. K. Stammers and D. I. Stuart, J. Med. Chem., 1996, 39, 1589-1600.
10. A. L. Hopkins, J. Ren, H. Tanaka, M. Baba, M. Okamato, D. I. Stuart and D. K. Stammers, J. Med. Chem., 1999, 42, 4500-4505.
11. N. R. El-Brollosy, P. T. Jørgensen, B. Dahan, A. M. Boel, E. B. Pedersen and C. Nielsen, J. Med. Chem., 2002, 45, 5721-5726.
12. L. Petersen, E. B. Pedersen and C. Nielsen, Synthesis, 2001, 4, 559-564.
13. See http://www.sehrodinger.com or: F. Mohamadi, N. G. J. Richards, W. C. Guida, R. Liskamp, M. Lipton, C. Caufield, G. Chang, T. Hendrickson and W. C. Still, J. Comp. Chem., 1990, 11, 440-467.
14. (a) J. Ren, C. Nichols, L. Bird, P. Chamberlain, K. Weaver, S. Short, D. I. Stuart and D. K. Stammers, J. Mol. Biol., 2001, 312, 795-805
15. (b) Structures were downloaded from the Protein Data Bank (PDB) http://www.rcsb.org/pdb/.
16. M. P. Allen, D. J. Tildesley, Computer simulation of liquids, Clarendon Press, Oxford, 1987.
17. T. A. Halgren, J. Comp. Chem., 1996, 17, 490-519.
18. RasMol version 2.6 was downloaded from http://www.umass.edu/microbio/rasmol/getras.htm.
19. A. L. Hopkins, J. Ren, R. M. Esnouf, B. E. Willcox, E. Y. Jones, C. Ross., T. Miyasaka, R. T. Walker, H. Tanaka, D. K. Stammers and D. I. Stuart, J. Med. Chem., 1996, 39, 1589-1600
20. (a) S. S. Klioze and F. P. Darmory, J. Org. Chem., 1975, 40, 1588-1592.
21. J. H. Burckhalter and H. C. Scarborough, J. Am. Pharm. Assoc., 1955, 44, 545-550.
22. H. Tanaka, H. Hayakawa and T. Miyasaka, Tetrahedron, 1982, 38, 2635-2642.
23. P. J. Garegg and B. Samuelsson, Carbohydr. Res., 1978, 67, 267-270.
24. H. Vorbrüggen, K. Krolikiewicz and B. Bennua, Chem. Ber., 1981, 114, 1234-1255.
25. 3), 114.61 (COC=CH), 138.97 (C-5), 142.88 (CH=C), 146.56, 150.71 (C-2, C-4), 150.38 (OCH), 162.64 (C-4), 190.65 (CO).
26. D-K. Kim, Y-W. Kim, J. Gam, G. Kim, J. Lim, N. Lee, H-T. Kim and K. H. Kim, J. Heterocyl. Chem., 1996, 33, 1275-1283.
27. M. Popovic, M. G. Sarngadharan, E. Read and R. C. Gallo, Science, 1984, 224, 497-500.
28. T. Mosmann, J. Immunol. Methods, 1983, 65, 55-63.
29. (a) D. Richman, C. K. Shih, I. Lowy, J. Rose, P. Prodanovich, S. Goff and J. Griffin, Proc. Natl. Acad. Sci. U.S.A., 1991, 88, 11241-11245
30. (b) H. Hara, T. Fujihashi, T. Sakata, A. Kaji and H. Kaji, AIDS Res. Hum. Retroviruses, 1997, 13, 6695-6705.